Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Q4 2024 Earnings Call Transcript February 28, 2025
Amneal Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.10031 EPS, expectations were $0.15.
Operator: Good morning, and welcome to the Amneal Pharmaceuticals, Inc. fourth quarter 2024 Earnings Conference Call. I would now like to turn the call over to Amneal’s Head of Investor Relations, Tony DiMeo. Please go ahead.
Tony DiMeo: Thank you for joining the Amneal...
